Multiple researches have investigated HER4 expression at the protein level in clinical breast cancer through immunohistochemistry with various anti-HER4 antibodies recognizing either the N- or C-terminus of HER4 or the reverse transcription mRNA-PCRRA-level (RT-PCR). The gene discussed is ERBB4; the disease is breast cancer.